journal article·2023-07-14Open access

Bioprinted 3D Bionic Scaffolds with Pancreatic Islets as a New Therapy for Type 1 Diabetes—Analysis of the Results of Preclinical Studies on a Mouse Model

Marta Klak, Michał Wszoła, Andrzej Berman, Anna Filip, Anna Kosowska, Joanna Olkowska-Truchanowicz, Michał Rachalewski, Grzegorz Tymicki, Tomasz Bryniarski, Marta Kołodziejska, Tomasz Dobrzański, Dominika Ujazdowska, Jarosław Wejman, Izabela Uhrynowska-Tyszkiewicz, Artur Kamiński

Abstract

Recently, tissue engineering, including 3D bioprinting of the pancreas, has acquired clinical significance and has become an outstanding potential method of customized treatment for type 1 diabetes mellitus. The study aimed to evaluate the function of 3D-bioprinted pancreatic petals with pancreatic islets in the murine model. A total of 60 NOD-SCID (Nonobese diabetic/severe combined immunodeficiency) mice were used in the study and divided into three groups: control group; IsletTx (porcine islets transplanted under the renal capsule); and 3D bioprint (3D-bioprinted pancreatic petals with islets transplanted under the skin, on dorsal muscles). Glucose, C-peptide concentrations, and histological analyses were performed. In the obtained results, significantly lower mean fasting glucose levels (mg/dL) were observed both in a 3D-bioprint group and in a group with islets transplanted under the renal capsule when compared with untreated animals. Differences were observed in all control points: 7th, 14th, and 28th days post-transplantation (129, 119, 118 vs. 140, 139, 140; p < 0.001). Glucose levels were lower on the 14th and 28th days in a group with bioprinted petals compared to the group with islets transplanted under the renal capsule. Immunohistochemical staining indicated the presence of secreted insulin-living pancreatic islets and neovascularization within 3D-bioprinted pancreatic petals after transplantation. In conclusion, bioprinted bionic petals significantly lowered plasma glucose concentration in studied model species.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Pancreatic function and diabetes · Pluripotent Stem Cells Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Foundation of Research and Science Development, 01-793 Warsaw, Poland

Polbionica Sp. z o.o., 01-793 Warsaw, Poland

Chair and Department of Histology and Embryology, Medical University of Warsaw, 02-004 Warsaw, Poland

Department of Transplantology and Central Tissue Bank, Medical University of Warsaw, 02-004 Warsaw, Poland

Center for Pathomorphological Diagnostics Sp. z o.o., 01-496 Warsaw, Poland

Funding

National Centre for Research and Development

References (49)

Show source-provided references
1. Bioprinting an Artificial Pancreas for Type 1 Diabetes10.1007/s11892-019-1166-x ↗
2. Improvement of islet transplantation by the fusion of islet cells with functional blood vessels10.15252/emmm.202012616 ↗
3. Pancreas collagen digestion during islet of Langerhans isolation—A prospective study10.1111/tri.13725 ↗
4. Biofabrication strategies for 3D in vitro models and regenerative medicine10.1038/s41578-018-0006-y ↗
5. A Photo-Crosslinkable Kidney ECM-Derived Bioink Accelerates Renal Tissue Formation10.1002/adhm.201800992 ↗
6. Oxidative Stress in Pancreatic Beta Cell Regeneration10.1155/2017/1930261 ↗
7. Tailoring mechanical properties of decellularized extracellular matrix bioink by vitamin B2-induced photo-crosslinking10.1016/j.actbio.2016.01.013 ↗
8. Jang, J. (2017). 3D Bioprinting and In Vitro Cardiovascular Tissue Modeling. Bioengineering, 4.10.3390/bioengineering4030071 ↗
9. Davidov, T., Efraim, Y., Hayam, R., Oieni, J., Baruch, L., and Machluf, M. (2021). Extracellular Matrix Hydrogels Originated from Different Organs Mediate Tissue-Specific Properties and Function. Int. J. Mol. Sci., 22.10.3390/ijms222111624 ↗
10. Di Piazza, E., Pandolfi, E., Cacciotti, I., Del Fattore, A., Tozzi, A.E., Secinaro, A., and Borro, L. (2021). Bioprinting Technology in Skin, Heart, Pancreas and Cartilage Tissues: Progress and Challenges in Clinical Practice. Int. J. Environ. Res. Public Heal., 18.10.3390/ijerph182010806 ↗
11. Klak, M., Łojszczyk, I., Berman, A., Tymicki, G., Adamiok-Ostrowska, A., Sierakowski, M., Olkowski, R., Szczepankiewicz, A.A., Kamiński, A., and Dobrzyń, A. (2021). Impact of Porcine Pancreas Decellularization Conditions on the Quality of Obtained dECM. Int. J. Mol. Sci., 22.10.3390/ijms22137005 ↗
12. Bioink based on the dECM for 3D bioprinting of bionic tissue, the first results obtained on murine model10.1016/j.bprint.2022.e00233 ↗
13. Kilkenny, C., Browne, W.J., Cuthill, I.C., Emerson, M., and Altman, D.G. (2010). Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research. PLoS Biol., 8.10.1371/journal.pbio.1000412 ↗
14. Successful engraftment, vascularization, and In vivo survival of 3D-bioprinted human lipoaspirate-derived adipose tissue10.1016/j.bprint.2019.e00065 ↗
15. Noninvasive in vivo 3D bioprinting10.1126/sciadv.aba7406 ↗
16. Functional and morphological studies of in vivo vascularization of 3D-bioprinted human fat grafts10.1016/j.bprint.2021.e00162 ↗
17. Klak, M., Kowalska, P., Dobrzański, T., Tymicki, G., Cywoniuk, P., Gomółka, M., Kosowska, K., Bryniarski, T., Berman, A., and Dobrzyń, A. (2021). Bionic Organs: Shear Forces Reduce Pancreatic Islet and Mammalian Cell Viability during the Process of 3D Bioprinting. Micromachines, 12.10.3390/mi12030304 ↗
18. Klak, M., Bryniarski, T., Kowalska, P., Gomolka, M., Tymicki, G., Kosowska, K., Cywoniuk, P., Dobrzanski, T., Turowski, P., and Wszola, M. (2020). Novel Strategies in Artificial Organ Development: What is the Future of Medicine?. Micromachines, 11.10.3390/mi11070646 ↗
19. Towards 3D-Bioprinting of Bionic Pancreas: Influence of the Bioink Composition during 3D Bioprinting of Pancreatic Scaffolds on the Functionality and Viability of Pancreatic Islets
20. Klak, M., Gomółka, M., Dobrzański, T., Tymicki, G., Cywoniuk, P., Kowalska, P., Kosowska, K., Bryniarski, T., Berman, A., and Dobrzyń, A. (2020). Irradiation with 365 nm and 405 nm wavelength shows differences in DNA damage of swine pancreatic islets. PLoS ONE, 15.10.1371/journal.pone.0235052 ↗
21. The use of animal models in diabetes research10.1111/j.1476-5381.2012.01911.x ↗
22. Wszola, M., Klak, M., Kosowska, A., Tymicki, G., Berman, A., Adamiok-Ostrowska, A., Olkowska-Truchanowicz, J., Uhrynowska-Tyszkiewicz, I., and Kaminski, A. (2021). Streptozotocin-Induced Diabetes in a Mouse Model (BALB/c) Is Not an Effective Model for Research on Transplantation Procedures in the Treatment of Type 1 Diabetes. Biomedicines, 9.10.3390/biomedicines9121790 ↗
23. The streptozotocin-induced diabetic nude mouse model: Differences between animals from different sources
24. C-Peptide determinations in islet xenotransplantation: A study in the pig-to-mouse model10.3727/000000001783986918 ↗
25. Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient10.1007/s00125-013-2906-0 ↗
26. The impact of islet mass, number of transplants, and time between transplants on graft function in a national islet transplant program10.1111/ajt.16785 ↗
27. Safety and Viability of Microencapsulated Human Islets Transplanted Into Diabetic Humans10.2337/dc09-0744 ↗
28. Effects of encapsulated porcine islets on glucose and C-peptide concentrations in diabetic nude mice 6 months after intraperitoneal transplantation10.1111/xen.12313 ↗
29. Clinical Benefit of Islet Xenotransplantation for the Treatment of Type 1 Diabetes10.1016/j.ebiom.2016.08.034 ↗
30. Clinical Porcine Islet Xenotransplantation Under Comprehensive Regulation10.1016/j.transproceed.2014.06.008 ↗
31. No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs10.1155/2014/727483 ↗
32. Insulin release in response to glucose from isolated mouse, rat, porcine, bovine, and human pancreatic islets
33. Current situation of clinical islet transplantation from allogeneic toward xenogeneic10.1111/1753-0407.13041 ↗
34. Long-Term Metabolic Control of Autoimmune Diabetes in Spontaneously Diabetic Nonobese Diabetic Mice by Nonvascularized Microencapsulated Adult Porcine Islets10.1097/TP.0b013e3181abbfc1 ↗
35. Production of genetically modified pigs expressing human insulin and C-peptide as a source of islets for xenotransplantation10.1007/s11248-019-00169-8 ↗
36. Food intake rather than blood glucose levels affects the pharmacokinetic profile of insulin aspart in pigs10.1111/bcpt.13574 ↗
37. Reduced insulin clearance contributes to the increased insulin levels after administration of glucagon-like peptide 1 in mice10.1007/s00125-005-1915-z ↗
38. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: A major obstacle for xenotransplantation in humans10.1016/0167-5699(93)90261-I ↗
39. Insulin Antibodies and Insulin Autoantibodies10.1111/j.1464-5491.1991.tb01553.x ↗
40. The pharmacokinetics of porcine C-peptide after intraperitoneal injection10.1111/xen.12505 ↗
41. A biomimetic approach for enhancing the in vivo half-life of peptides10.1038/nchembio.1907 ↗
42. Pancreatic islet plasticity: Interspecies comparison of islet architecture and composition10.4161/isl.2.3.11815 ↗
43. Porcine Islet Isolation, Cellular Composition and Secretory Response10.1055/s-2007-1009296 ↗
44. Isokinetic gradient centrifugation prolongs survival of pig islets xenografted into mice10.1007/s001090050331 ↗
45. Measurement of pulsatile insulin secretion in the rat: Direct sampling from the hepatic portal vein
46. Skjaervold, N.K., Knai, K., and Elvemo, N. (2018). Some oscillatory phenomena of blood glucose regulation: An exploratory pilot study in pigs. PLoS ONE, 13.10.1371/journal.pone.0194826 ↗
47. 3D Bioprinting of Functional Islets of Langerhans in an Alginate/Methylcellulose Hydrogel Blend10.1002/adhm.201801631 ↗
48. Fabrication of three-dimensional bioplotted hydrogel scaffolds for islets of Langerhans transplantation10.1088/1758-5090/7/2/025009 ↗
49. Alginate-based tissue-specific bioinks for multi-material 3D-bioprinting of pancreatic islets and blood vessels: A step towards vascularized pancreas grafts10.1016/j.bprint.2021.e00163 ↗